<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01295398</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A01237-32</org_study_id>
    <secondary_id>2010-24</secondary_id>
    <nct_id>NCT01295398</nct_id>
  </id_info>
  <brief_title>Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis</brief_title>
  <official_title>Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigators study is to compare in children aged less than 18 months and
      hospitalized for an acute viral bronchiolitis the efficacy of the HS 3% (Mucoclear®, sterile
      ampoules of 4 ml) nebulised with a conventional jet-nebulizer (particles diameter of 4-5 µm),
      or with a jet-nebulizer adapted for infants (particles diameter of 2-2.5 µm), or with a
      mesh-nebulizer adapted for infants (particles diameter of 2-2.5 µm).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the improvement of the clinical score of severity at the 48th hour between the 3 groups of children</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number of children requiring oxygen</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tolerance of the nebulisations</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of complications.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of parenteral nutrition</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Acute Viral Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>conventional jet-nebulizer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>(particles diameter of 4-5 µm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>a jet-nebulizer adapted for infants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(particles diameter of 2-2.5 µm),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>a mesh-nebulizer adapted for infants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(particles diameter of 2-2.5 µm).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nebulisations</intervention_name>
    <arm_group_label>conventional jet-nebulizer</arm_group_label>
    <arm_group_label>a jet-nebulizer adapted for infants</arm_group_label>
    <arm_group_label>a mesh-nebulizer adapted for infants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infant of less than 18 months old

          -  infant hospitalized for a 1st episode of bronchiolitis defined as a 1st episode of
             respiratory difficulty with sibilant and\or crépitants in a viral context (head cold
             and\or cough and\or fever and\or notion of contage)

          -  Necessity of an clinical score upper to 4. This clinical score, described by Wang in
             1992, is the clinical score classically used in the studies concerning the
             acute(sharp) bronchiolitis of the infant ( 8,9,12 ). He(it) is at most on 12 points.

          -  absence of respiratory décompensation requiring an admission in Unity of Pediatric
             Intensive care

          -  signature of the Informed consent

          -  Membership in a national insurance

        Exclusion Criteria:

          -  Refusal of the parents to participate in the study

          -  18-month-old infant hospitalized for acute(sharp) bronchiolitis with a clinical score
             lower than 4.

          -  signs of respiratory décompensation requiring a transfer in resuscitation, signs of
             hypercapnie or episodes of apneas

          -  histories of bronchiolitis or asthma of the infant

          -  cardiac underlying pathology, respiratory, neuromuscular, immunodeficient or former
             premature of less of 34 weeks of amenorrhoea and less than 3 months of corrected age.

          -  child having set within 6 hours preceding the inclusion a treatment by
             bronchodilatateurs or corticoids by systematic or inhaled way.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD BELAIGUES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique hôpitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2011</study_first_submitted>
  <study_first_submitted_qc>February 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2011</study_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis, Viral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

